tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Opthea Advances Sozinibercept in Phase 3 Trials for Vision Improvement
Company AnnouncementsOpthea Advances Sozinibercept in Phase 3 Trials for Vision Improvement
1h ago
Opthea Limited Announces New Securities Quotation
PremiumCompany Announcements
Opthea Limited Announces New Securities Quotation
1d ago
Opthea to host investor days in New York, Australia
PremiumThe Fly
Opthea to host investor days in New York, Australia
23d ago
OPT
Opthea to Host Investor Days Highlighting Sozinibercept’s Potential in Wet AMD
PremiumCompany Announcements
Opthea to Host Investor Days Highlighting Sozinibercept’s Potential in Wet AMD
23d ago
Opthea announces publication on Phase 1b trial of sozinibercept in DME
PremiumThe Fly
Opthea announces publication on Phase 1b trial of sozinibercept in DME
24d ago
OPT
Opthea’s Promising Results in Diabetic Macular Edema Trial Published
PremiumCompany AnnouncementsOpthea’s Promising Results in Diabetic Macular Edema Trial Published
24d ago
Opthea Limited Issues New Shares on ASX
Premium
Company Announcements
Opthea Limited Issues New Shares on ASX
1M ago
Opthea Limited Issues New Equity Securities
Premium
Company Announcements
Opthea Limited Issues New Equity Securities
1M ago
Opthea Limited Reports Cessation of Securities
PremiumCompany Announcements
Opthea Limited Reports Cessation of Securities
1M ago
Opthea Limited Issues New Unquoted Equity Securities
PremiumCompany Announcements
Opthea Limited Issues New Unquoted Equity Securities
1M ago
Opthea Limited Director Acquires Significant Stock Options
PremiumCompany Announcements
Opthea Limited Director Acquires Significant Stock Options
2M ago
Opthea Limited Announces Director’s New Option Grant
PremiumCompany Announcements
Opthea Limited Announces Director’s New Option Grant
2M ago
Opthea Limited Director’s Interest Change
PremiumCompany AnnouncementsOpthea Limited Director’s Interest Change
2M ago
Opthea Limited Updates Director’s Stakeholding
Premium
Company Announcements
Opthea Limited Updates Director’s Stakeholding
2M ago
Opthea Limited Updates on Director’s Stock Options
Premium
Company Announcements
Opthea Limited Updates on Director’s Stock Options
2M ago
Opthea’s Director Increases Stake with New Options
PremiumCompany Announcements
Opthea’s Director Increases Stake with New Options
2M ago
Opthea appoints Kathy Connell to board of directors
PremiumThe Fly
Opthea appoints Kathy Connell to board of directors
3M ago
OPT
Opthea Limited Appoints New Director with Stock Options
PremiumCompany Announcements
Opthea Limited Appoints New Director with Stock Options
3M ago
Opthea Secures A$15.9 Million Boost for R&D Efforts
PremiumCompany Announcements
Opthea Secures A$15.9 Million Boost for R&D Efforts
3M ago
Opthea Limited Announces Successful AGM Resolutions
PremiumCompany AnnouncementsOpthea Limited Announces Successful AGM Resolutions
3M ago
Opthea Limited Strengthens Board Amidst Key Data Preparations
Premium
Company Announcements
Opthea Limited Strengthens Board Amidst Key Data Preparations
3M ago
Opthea Limited Advances in Wet AMD Treatment
Premium
Company Announcements
Opthea Limited Advances in Wet AMD Treatment
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >